Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1998 May;78(3):F185–F188. doi: 10.1136/fn.78.3.f185

Randomised controlled trial of L-carnitine as a nutritional supplement in preterm infants

G Shortland, J Walter, C Stroud, P Fleming, B Speidel, N Marlow
PMCID: PMC1720799  PMID: 9713029

Abstract

AIMS—To evaluate the effect of L-carnitine supplementation (25 mg/kg/d) on the growth and incidence of hypoglycaemia in preterm infants.
METHODS—A double blind, placebo controlled randomised trial, stratified for gestational age, was conducted of 86 preterm infants between 28 and 34 gestational weeks. The median gestational ages in the carnitine group and placebo groups were 30.7 weeks (range 28.0to 33.6) and 31.4 weeks (range 28.0 to 33.9), respectively. The median birthweights were 1.557 kg (range 0.944 to 2.275) and 1.645kg (range 0.885 to 2.545), respectively.
RESULTS—Mean plasma free carnitine concentrations were below values for normal term infants in both groups on day 1 (carnitine group 44.8 µmol/l, placebo group 25.5 µmol/l) in the placebo group on day 7 (50.7 µmol/l), but in neither group on days 14 and 28. Total, free, and acylcarnitine concentrations were significantly increased in both urine and blood in the L-carnitine group. There was no significant difference between the placebo and carnitine supplemented groups in growth rate, as assessed by weight, length, skinfold thickness and head circumference measurements, or in the incidence of episodes of hypoglycaemia.
CONCLUSION—The addition of carnitine as a nutritional supplement at a dose of 25mg/kg/day did not improve growth in our group of preterm infants nor protect them from episodes of hypoglycaemia.



Full Text

The Full Text of this article is available as a PDF (96.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonner C. M., DeBrie K. L., Hug G., Landrigan E., Taylor B. J. Effects of parenteral L-carnitine supplementation on fat metabolism and nutrition in premature neonates. J Pediatr. 1995 Feb;126(2):287–292. doi: 10.1016/s0022-3476(95)70562-7. [DOI] [PubMed] [Google Scholar]
  2. Bougneres P. F., Lemmel C., Ferré P., Bier D. M. Ketone body transport in the human neonate and infant. J Clin Invest. 1986 Jan;77(1):42–48. doi: 10.1172/JCI112299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cederblad G., Lindstedt S. A method for the determination of carnitine in the picomole range. Clin Chim Acta. 1972 Mar;37:235–243. doi: 10.1016/0009-8981(72)90438-x. [DOI] [PubMed] [Google Scholar]
  4. Cederblad G., Svenningsen N. Plasma carnitine and breast milk carnitine intake in premature infants. J Pediatr Gastroenterol Nutr. 1986 Jul-Aug;5(4):616–621. doi: 10.1097/00005176-198607000-00019. [DOI] [PubMed] [Google Scholar]
  5. Hawdon J. M., Ward Platt M. P., Aynsley-Green A. Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Arch Dis Child. 1992 Apr;67(4 Spec No):357–365. doi: 10.1136/adc.67.4_spec_no.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Melegh B., Kerner J., Sándor A., Vincellér M., Kispál G. Effects of oral L-carnitine supplementation in low-birth-weight premature infants maintained on human milk. Biol Neonate. 1987;51(4):185–193. doi: 10.1159/000242650. [DOI] [PubMed] [Google Scholar]
  7. Melegh B., Szücs L., Kerner J., Sándor A. Changes of plasma free amino acids and renal clearances of carnitines in premature infants during L-carnitine-supplemented human milk feeding. J Pediatr Gastroenterol Nutr. 1988 May-Jun;7(3):424–429. doi: 10.1097/00005176-198805000-00019. [DOI] [PubMed] [Google Scholar]
  8. Olson A. L., Rebouche C. J. gamma-Butyrobetaine hydroxylase activity is not rate limiting for carnitine biosynthesis in the human infant. J Nutr. 1987 Jun;117(6):1024–1031. doi: 10.1093/jn/117.6.1024. [DOI] [PubMed] [Google Scholar]
  9. Orzali A., Donzelli F., Enzi G., Rubaltelli F. F. Effect of carnitine on lipid metabolism in the newborn. I. Carnitine supplementation during total parenteral nutrition in the first 48 hours of life. Biol Neonate. 1983;43(3-4):186–190. doi: 10.1159/000241627. [DOI] [PubMed] [Google Scholar]
  10. Rovamo L. M., Salmenperä L., Arjomaa P., Raivio K. O. Carnitine during prolonged breast feeding. Pediatr Res. 1986 Aug;20(8):806–809. doi: 10.1203/00006450-198608000-00022. [DOI] [PubMed] [Google Scholar]
  11. Rubaltelli F. F., Orzali A., Rinaldo P., Donzelli F., Carnielli V. Carnitine and the premature. Biol Neonate. 1987;52 (Suppl 1):65–77. doi: 10.1159/000242740. [DOI] [PubMed] [Google Scholar]
  12. Schiff D., Chan G., Seccombe D., Hahn P. Plasma carnitine levels during intravenous feeding of the neonate. J Pediatr. 1979 Dec;95(6):1043–1046. doi: 10.1016/s0022-3476(79)80306-6. [DOI] [PubMed] [Google Scholar]
  13. Shenai J. P., Borum P. R., Mohan P., Donlevy S. C. Carnitine status at birth of newborn infants of varying gestation. Pediatr Res. 1983 Jul;17(7):579–582. doi: 10.1203/00006450-198307000-00012. [DOI] [PubMed] [Google Scholar]
  14. Warshaw J. B., Curry E. Comparison of serum carnitine and ketone body concentrations in breast- and in formula-fed newborn infants. J Pediatr. 1980 Jul;97(1):122–125. doi: 10.1016/s0022-3476(80)80151-x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES